August 4, 2020
Canadian hospitals using new therapies to treat critically ill COVID-19 patients
More than six months later and thanks to a flurry of international research, some new therapies have emerged. In recent weeks, doctors say an anti-inflammatory steroid, dexamethasone, has become standard care in intensive care units across the country. To read the full article, click here.